Covered recipient · General Payments record
MARK S KLEPPER
Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease
General Payments · PY2018–2024
$1,305.12
- Reported across 90 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $312.50 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Penumbra, Inc. | $139.74 | 1 |
| GENZYME CORPORATION | $133.13 | 8 |
| Acerta Pharma LLC | $20.25 | 1 |
| ANI Pharmaceuticals, Inc. | $19.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. | $19.38 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091165834 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.25 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104214523 | CMS |
| GENZYME CORPORATION | $14.52 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139969663 | CMS |
| GENZYME CORPORATION | $19.88 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139969667 | CMS |
| GENZYME CORPORATION | $13.56 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139969671 | CMS |
| GENZYME CORPORATION | $7.82 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139969685 | CMS |
| GENZYME CORPORATION | $11.45 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139969687 | CMS |
| GENZYME CORPORATION | $30.40 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139969701 | CMS |
| GENZYME CORPORATION | $22.94 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139969703 | CMS |
| GENZYME CORPORATION | $12.56 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139969707 | CMS |
| Penumbra, Inc. | $139.74 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1076211072 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.